Mkts

Pacira BioSciences, Inc.

NASDAQ: PCRX
$36.43+0.01 (+0.03%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
36.4236.45
52-week range
18.8036.66
Today
Open36.42
Previous close36.43
Volume—
Valuation
Market cap1.46B
P/E ratio99.78×
EPS (TTM)0.35
Income & risk
Dividend / yield—
Beta0.16
Avg volume1.08M
Discussion

PCRX News

Stories mentioning PCRX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue177,376196,873179,516181,099168,923187,253168,573178,023
Cost of Goods Sold36,41340,29934,27840,86634,30639,88638,86444,262
Gross Profit140,963156,574145,238140,233134,617147,367129,709133,761
Operating Expenses
Research & Development28,07237,80425,96628,20025,34223,89719,10420,338
Sales General & Admin93,944101,60891,79788,57886,77679,61474,33368,126
Total Operating Expenses
Operating Income (Loss)6,9022,3406,3628,4991,99024,704(139,527)28,240
Interest Income1,9302,2958,5345,0086,8955,5555,4824,749
Interest Expense
Other Expense(135.00)(172.00)(110.00)(10,739)4,401(53.00)(122.00)(39.00)
Pretax Income4,998571.009,524(1,927)8,70625,526(138,856)36,584
Tax Provision2,082(1,066)4,0922,9203,8949,4854,61017,698
Net Income (Loss)2,9161,6375,432(4,847)4,81216,041(143,466)18,886
Earnings Per Share (Basic)0.070.040.12(0.11)0.100.35(3.11)0.41
Earnings Per Share (Diluted)0.070.040.12(0.11)0.100.35(3.11)0.39
Weighted Average Shares Outstanding (Basic)40,46144,56644,03845,45946,27546,24546,13446,174
Weighted Average Shares Outstanding (Diluted)40,91045,04244,45945,45946,52646,24546,13450,539

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About PCRX

Pacira BioSciences, Inc. (NASDAQ: PCRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol PCRX. It last traded at $36.43 (Nov 6, 2026, 4:00 PM ET), up 0.0% on the day. That gives Pacira BioSciences a market capitalisation of $1.5B and a price-to-earnings ratio of 99.8.

Over the past 52 weeks PCRX has traded between $18.80 and $36.66.

Revenue for the quarter ended Mar 31, 2026 was $177.4M; net income $2.9M. Revenue was up 5.0% from $168.9M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$177.4M$2.9M1.6%
Dec 31, 2025$196.9M$1.6M0.8%
Sep 30, 2025$179.5M$5.4M3.0%
Jun 30, 2025$181.1M-$4.8M-2.7%

From Pacira BioSciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…